Literature DB >> 29175958

Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Cody A Siciliano1,2, Kaustuv Saha3, Erin S Calipari1,4, Steve C Fordahl1, Rong Chen1, Habibeh Khoshbouei3, Sara R Jones5.   

Abstract

Cocaine abuse disrupts dopamine system function, and reduces cocaine inhibition of the dopamine transporter (DAT), which results in tolerance. Although tolerance is a hallmark of cocaine addiction and a DSM-V criterion for substance abuse disorders, the molecular adaptations producing tolerance are unknown, and testing the impact of DAT changes on drug taking behaviors has proven difficult. In regard to treatment, amphetamine has shown efficacy in reducing cocaine intake; however, the mechanisms underlying these effects have not been explored. The goals of this study were twofold; we sought to (1) identify the molecular mechanisms by which cocaine exposure produces tolerance and (2) determine whether amphetamine-induced reductions in cocaine intake are connected to these mechanisms. Using cocaine self-administration and fast-scan cyclic voltammetry in male rats, we show that low-dose, continuous amphetamine treatment, during self-administration or abstinence, completely reversed cocaine tolerance. Amphetamine treatment also reversed escalated cocaine intake and decreased motivation to obtain cocaine as measured in a behavioral economics task, thereby linking tolerance to multiple facets of cocaine use. Finally, using fluorescence resonance energy transfer imaging, we found that cocaine tolerance is associated with the formation of DAT-DAT complexes, and that amphetamine disperses these complexes. In addition to extending our basic understanding of DATs and their role in cocaine reinforcement, we serendipitously identified a novel therapeutic target: DAT oligomer complexes. We show that dispersion of oligomers is concomitant with reduced cocaine intake, and propose that pharmacotherapeutics aimed at these complexes may have potential for cocaine addiction treatment.SIGNIFICANCE STATEMENT Tolerance to cocaine's subjective effects is a cardinal symptom of cocaine addiction and a DSM-V criterion for substance abuse disorders. However, elucidating the molecular adaptions that produce tolerance and determining its behavioral impact have proven difficult. Using cocaine self-administration in rats, we link tolerance to cocaine effects at the dopamine transporter (DAT) with aberrant cocaine-taking behaviors. Further, tolerance was associated with multi-DAT complexes, which formed after cocaine exposure. Treatment with amphetamine deconstructed DAT complexes, reversed tolerance, and decreased cocaine seeking. These data describe the behavioral consequence of cocaine tolerance, provide a putative mechanism for its development, and suggest that compounds that disperse DAT complexes may be efficacious treatments for cocaine addiction.
Copyright © 2018 the authors 0270-6474/18/380484-14$15.00/0.

Entities:  

Keywords:  agonist therapy; behavioral economics; nucleus accumbens; self-administration; tolerance; voltammetry

Mesh:

Substances:

Year:  2017        PMID: 29175958      PMCID: PMC5761621          DOI: 10.1523/JNEUROSCI.2604-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats.

Authors:  Rajkumar J Sevak; W Anthony Owens; Wouter Koek; Aurelio Galli; Lynette C Daws; Charles P France
Journal:  J Neurochem       Date:  2007-01-08       Impact factor: 5.372

2.  PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.

Authors:  Michael A Nader; Drake Morgan; H Donald Gage; Susan H Nader; Tonya L Calhoun; Nancy Buchheimer; Richard Ehrenkaufer; Robert H Mach
Journal:  Nat Neurosci       Date:  2006-07-09       Impact factor: 24.884

3.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

4.  Cocaine self-administration in rats: threshold procedures.

Authors:  Erik B Oleson; David C S Roberts
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Authors:  Jacob Eriksen; Trine Nygaard Jørgensen; Ulrik Gether
Journal:  J Neurochem       Date:  2010-01-18       Impact factor: 5.372

6.  NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.

Authors:  Magdalena M Grabowska; Amicia D Elliott; David J DeGraff; Philip D Anderson; Govindaraj Anumanthan; Hironobu Yamashita; Qian Sun; David B Friedman; David L Hachey; Xiuping Yu; Jonathan H Sheehan; Jung-Mo Ahn; Ganesh V Raj; David W Piston; Richard M Gronostajski; Robert J Matusik
Journal:  Mol Endocrinol       Date:  2014-05-06

7.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

8.  Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge.

Authors:  Jon D Gaffaney; Madhur Shetty; Bruce Felts; Akula-Bala Pramod; James D Foster; L Keith Henry; Roxanne A Vaughan
Journal:  Neurochem Int       Date:  2013-11-20       Impact factor: 3.921

9.  Quantitative FRET imaging of leptin receptor oligomerization kinetics in single cells.

Authors:  Eva Biener; Madia Charlier; V Krishnan Ramanujan; Nathalie Daniel; Avital Eisenberg; Christian Bjørbaek; Brian Herman; Arieh Gertler; Jean Djiane
Journal:  Biol Cell       Date:  2005-12       Impact factor: 4.458

10.  Imaging kinase--AKAP79--phosphatase scaffold complexes at the plasma membrane in living cells using FRET microscopy.

Authors:  Seth F Oliveria; Lisa L Gomez; Mark L Dell'Acqua
Journal:  J Cell Biol       Date:  2002-12-30       Impact factor: 10.539

View more
  20 in total

1.  Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

Authors:  Mary Hongying Cheng; Luca Ponzoni; Tatiana Sorkina; Ji Young Lee; She Zhang; Alexander Sorkin; Ivet Bahar
Journal:  Neuropharmacology       Date:  2019-06-20       Impact factor: 5.250

2.  Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Authors:  Amy R Johnson; Matthew L Banks; Dana E Selley; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

3.  Operant Costs Modulate Dopamine Release to Self-Administered Cocaine.

Authors:  Idaira Oliva; Matthew J Wanat
Journal:  J Neurosci       Date:  2018-12-17       Impact factor: 6.167

Review 4.  Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances.

Authors:  Tyler W E Steele; Jose M Eltit
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

5.  Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.

Authors:  Zachary D Brodnik; Wei Xu; Aashita Batra; Stacia I Lewandowski; Christina M Ruiz; Ole V Mortensen; Sandhya Kortagere; Stephen V Mahler; Rodrigo A España
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

Review 6.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

Review 7.  Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Authors:  Douglas R Miller; Mengfei Bu; Adithya Gopinath; Luis R Martinez; Habibeh Khoshbouei
Journal:  J Pharmacol Exp Ther       Date:  2021-09-17       Impact factor: 4.402

8.  Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.

Authors:  I P Alonso; J A Pino; S Kortagere; G E Torres; R A España
Journal:  Neuropsychopharmacology       Date:  2020-10-08       Impact factor: 7.853

9.  Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter.

Authors:  Liang Xu; Liao Y Chen
Journal:  J Chem Inf Model       Date:  2020-07-21       Impact factor: 4.956

10.  Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.

Authors:  Florence Allain; Benoît Delignat-Lavaud; Marie-Pierre Beaudoin; Vincent Jacquemet; Terry E Robinson; Louis-Eric Trudeau; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2020-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.